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Aims Echocardiography is vital in the routine assessment and management of atrial fibrillation (AF). We performed a sys-
tematic review of the validity and reproducibility of echocardiographic left ventricular systolic and diastolic function
in AF, and optimal acquisition methods.
...................................................................................................................................................................................................
Methods
and results
Online databases were searched for studies in patients with AF at the time of echocardiography (1960 to August
2015), prospectively registered with PROSPERO (CRD42015025297). The systematic review included 32 studies
from 3 066 search results (1 968 patients with AF). Average age was 67 years, 33% were women, mean LVEF 53%
(±10%), and average E/e’ 11.7 (±2.7). Data on the validity and reproducibility of systolic indices were extremely
limited. In contrast, diastolic parameters demonstrated correlation with invasive filling pressure and adequate re-
producibility: E/e’ (n= 444) r = 0.47 to 0.79; IVRT (n= 177) r = –0.70 to –0.95; E/Vp‘ (n= 55) r = 0.63 and 0.65; pul-
monary vein diastolic flow (n= 67) r = –0.80 and –0.91. Elevated E/e’ (>15) was associated with functional capacity,
quality of life, and impaired prognosis. For optimal acquisition in AF patients, cardiac cycles with controlled heart
rate (<100 beats/min) and similar preceding and pre-preceding RR intervals are required. Cardiac cycle length and
equivalence were more important than the number of beats averaged.
...................................................................................................................................................................................................
Conclusion With careful selection of appropriate cardiac cycles, echocardiography is a valid tool to identify diastolic dysfunction
in AF, and E/e’ is an independent marker of clinical status and adverse prognosis. However, data on systolic function
was extremely limited and requires further prospective study and assessment of variability in clinical practice.
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Introduction
Atrial fibrillation (AF) is an increasingly common heart rhythm dis-
turbance that leads to frequent hospital admissions, heart failure,
stroke, and higher mortality.1 There is a close relationship between
AF and heart failure, with numerous risk factors common to both
conditions, and shared pathophysiology in patients with both reduc-
ed2 and preserved3 left ventricular ejection fraction (LVEF).
Depending on the type of AF, the rate of prevalent heart failure is be-
tween 33% and 56%4; hence clinicians treating patients with AF need
reliable information on both systolic and diastolic left ventricular (LV)
function. Echocardiography is the primary tool used in clinical
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practice and provides vital guidance to determine appropriate use of
anticoagulation, rate-control therapy, and rhythm-control strategies,
as well as important information on co-existing or precipitating path-
ology and prognostic data.5 All of these important clinical decisions
require echocardiographic measures that are valid and reproducible,
regardless of cardiac rhythm.
The loss of synchronized atrial contraction and altered left atrial
pressure is likely to affect the reproducibility of echocardiographic
measurements in AF. Factors that have been implicated include the
ratio of preceding to pre-preceding cycle length and heart rate during
image acquisition. Both of these influence the volume of ejection and
consequently the results of the most commonly-used measurements
of LV function, particularly where these are taken over a number of
cardiac cycles. Joint guidelines published by the American Society of
Echocardiography and the European Association of Cardiovascular
Imaging suggest a minimum of five beats in AF patients, although this
is based on consensus opinion.6 For diastolic function, the British
Society of Echocardiography recommends averaging over 5–10 beats
during cycle lengths equivalent to a heart rate between 60–80 beats/
min.
We performed a systematic and focused review of published lit-
erature on the use of echocardiography for determination of systolic
and diastolic LV function in patients with AF. Our main objectives
were to assess the validity of echocardiographic measures whilst in
AF, both against other modalities and clinical outcomes, and the re-
producibility of these parameters. A further objective was to appraise
the acquisition of images. This includes the optimal number of re-
peated measurements and cardiac cycle lengths that would reduce
variability of systolic and diastolic evaluation and allow confidence in
the echocardiographic diagnosis of systolic or diastolic dysfunction
in AF.
Methods
Eligibility criteria and search strategy
All studies reporting validity or reproducibility data on LV systolic or dia-
stolic function in AF patients were examined. There was no restriction
on study design, however only adult populations with AF at the time of
echocardiography were considered. Exclusion criteria included case re-
ports, animal studies and studies that were only published in abstract
form or in a language other than English. All editorials, commentaries and
informal reviews of other literature were also excluded, as were studies
only assessing left atrial size or function. An online search was performed
of PubMed and the Cochrane library (inception to December 2014, and
then extended to August 2015), including the broad terms ‘atrial fibrilla-
tion’ and ‘echocardiography’ using MESH headings and title/abstract
searches, including syntax variations. We also conducted manual screen-
ing of relevant reviews and reference lists. The systematic review was re-
ported according to the Preferred Reporting Items for Systematic
reviews and Meta-Analyses (PRISMA) guidelines and prospectively regis-
tered with the PROSPERO database of systematic reviews (http://www.
crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42015025297).
Outcomes
The primary outcomes of interest were echocardiographic measures of
LV systolic and diastolic function. For systolic function, these included
LVEF using biplane Simpson’s method or 3D volume assessment and
measurement of strain (peak longitudinal systolic strain [PLSS] and global
longitudinal strain [GLS]). For diastolic function, we included assessment
of isovolumic relaxation time (IVRT), mitral E-wave deceleration time,
the ratio of mitral peak E velocity to tissue Doppler early diastolic velocity
e’ (E/e’), pulmonary venous (PV) flow diastolic deceleration time (PVd-
DT), and the ratio of mitral peak E velocity to the velocity of diastolic
flow propagation measured with colour Doppler M-mode (E/Vp). For all
parameters, we extracted data on validity against other modalities (for
example, pulmonary capillary wedge pressure [PCWP] on right heart
catheterization) and estimates of intra and inter-operator reproducibility.
We also noted the method by which studies collected data, including the
number of repeated measures and cardiac cycle lengths. A secondary
outcome was to record average values of echocardiographic measures in
AF, for comparison with published norms in patients with sinus rhythm.
Data collection and quality assessment
Data on validity (against other modalities and any relevant clinical associ-
ations) and reproducibility (both intra- and inter-observer variability)
were extracted by three investigators independently (MM, ES, and DK),
and tabulated in a standardized data-extraction form. Study quality was
assessed using the Risk of Bias Assessment Tool for Non-randomized
Studies (RoBANS), which addresses selection bias, exposure measure-
ment, blinding, the completeness of outcome data, and selectivity of re-
porting.7 Risk of bias was assessed by two investigators independently
(MM and ES) and discrepancies resolved by group discussion and add-
itional adjudication (DK).
Data synthesis and statistical analysis
Baseline demographics were pooled from all studies providing suitable
data (including variance where applicable), and are summarized as a
weighted mean according to sample size. Outcomes were synthesized
qualitatively. Meta-analysis of comparative data between AF and sinus
rhythm was not possible due to the limited studies available and a lack of
published data on the variance of outcome measures. Analyses were per-
formed on Stata Version 14.1 (StataCorp LP, Texas).
Results
The search strategy identified a total of 3 066 records of which 2 945
were excluded, primarily due to lack of relevance to echocardiog-
raphy in AF, and a further 89 excluded after full text review (Figure 1).
What’s new?
• The new 2016 ESC Guidelines on AF recommend echocardi-
ography in all AF patients to guide management (I C).
• In this systematic review, data on the validity and reproducibil-
ity of systolic indices in AF patients were extremely limited;
the best measure of systolic function and acquisition method
in AF are priorities for future research.
• Diastolic parameters in AF have been validated against invasive
filling pressure with adequate reproducibility. Elevated E/e’
(>15) is also associated with functional capacity, quality of life,
and impaired prognosis.
• Measurement of systolic and diastolic function in AF is
optimized when the two preceding cardiac cycles have similar
RR-intervals and the heart rate is controlled (<100 beats/min).
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Thirty-two observational studies were included in the final review,8–39
the majority of which were single-centre studies. Table 1 highlights the
populations examined and the key findings relating to patients with
AF. There was marked heterogeneity in the type of AF (paroxysmal,
persistent, or permanent), heart failure status, LVEF and clinical demo-
graphics. The weighted-average age was 66.9 years and a third were
women (Table 2). Overall, studies recorded a mean LVEF of 52.5%
and average E/e’ of 11.7 in AF. Heart rate was usually below 80 beats/
min, with a minority of studies excluding patients above a specific
heart rate target (typically >100 beats/min). Many studies excluded pa-
tients with AF due to valvular heart disease. Only four studies enrolled
100 or more patients, and there were frequent references to selecting
participants with adequate quality echocardiographic images. As a re-
sult, the risk of bias for selection and blinding were universally high, al-
though in other domains, the risk of bias was more variable (see
Supplementary material online, Table S1).
Systolic function: validity and
reproducibility
Data for the validity of systolic function indices in patients with AF
were extremely limited. We found no external validation studies (for
example, comparing results with other modalities such as cardiac
magnetic resonance or nuclear imaging). There were however ex-
amples of within-study or internal validation (such as correlation of
new 3D techniques with conventional biplane Simpsons, or strain
with LVEF).9,33 With respect to clinical outcomes, one study showed
that LV systolic parameters were unrelated to exercise capacity in 73
stable AF patients.17 However, in a study of 196 patients with persist-
ent AF, baseline GLS was independently associated with a composite
of cardiovascular death, non-fatal stroke and heart failure hospitaliza-
tion after 21 (±10) months follow-up.32 This relationship persisted in
multivariate analysis (hazard ratio 1.12, 95% CI 1.02–1.23, P= 0.014),
whereas LVEF and other measures of systolic function were not inde-
pendently significant. The optimal, post-hoc defined GLS cut-off for
predicting event-free survival was –12.5%, and this incrementally
added to clinical predictors of adverse outcome.32
Reproducibility of systolic function indices are summarized in
Table 3. A wide array of study and acquisition methods made data
synthesis unfeasible, however reproducibility was reasonable in AF
patients using single-beat methods.19,29,31,32,39 One study examining
AF patients with irregularity on their electrocardiogram found that to
achieve similar variability for cardiac output in AF as with sinus
rhythm, three times the number of beats were required (13 vs. 4
beats, respectively).12 In contrast, although there was higher inter-
observer variability for 3D-LVEF using conventional 4-beat acquisi-
tion in AF compared to sinus rhythm (17.9% vs. 3.9%, respectively),
when using single-beat acquisition, reproducibility was similar regard-
less of heart rhythm (5.6% in AF, vs. 4.5% in sinus rhythm).29
Diastolic function: validity and
reproducibility
Considerably more data were available for the use of diastolic param-
eters in AF (Table 4). Twenty studies provided correlations with inva-
sive PCWP on right heart catheterization for a range of diastolic
indices. IVRT was assessed in four studies (n= 177) and inverse cor-
relations with PCWP were all highly statistically significant, ranging
from –0.70 to –0.95.11,22,34,35 Seven studies examined mitral deceler-
ation time (n= 324), of which 2 found no correlation with PCWP27,30
and 5 identified moderate inverse correlation.10,21,22,34,35 All 5 studies
of E/e’ (n= 444) showed significant association with PCWP, ranging
from 0.47 to 0.79, and including e’ derived from both septal and lat-
eral positions.15,20,27,30,36 Using a dual Doppler method, the combin-
ation of E/e’ and the time between E and e’ (cut-points at >14.6
and >34 ms, respectively), improved the sensitivity and specificity for
predicting elevated PCWP vs. either alone.36 Compared to those in
sinus rhythm, AF patients demonstrated a similar correlation with
PCWP for the ratio of IVRT to time between E and e’ in patients with
mitral valve disease.11 E/Vp and the deceleration time of PV diastolic
flow were each assessed in 2 studies (n= 55 and n= 67, respectively)
and both parameters showed a high degree of correlation with
PCWP.10,21,22,24 Diastolic PV flow was better than mitral indices for
estimating PCWP in one study of 35 AF patients.10
In regard to clinical outcomes, a retrospective analysis of 230 AF
patients identified that septal E/e’ >15 was independently associated
with mortality during follow-up of 245 (± 200) days, both in patients
with impaired and preserved LVEF.23 Deceleration time <150 ms was
associated with mortality during follow-up of 25 (± 11) months in AF
patients with LVEF <40% who had been hospitalized for heart failure,
with a similar impact in AF patients (n= 40) as those with sinus
rhythm (n= 100).25 Diastolic indices, including E/e’ and E/Vp, have
also been shown to correlate with B-type natriuretic peptide (BNP),
a biomarker strongly associated with adverse prognosis.15,24 E/e’ was
the only echocardiographic variable of LV function related to exer-
cise capacity in 73 patients with AF (multivariate adjusted coefficient
b = –0.12; P = 0.032).17 The same group also showed in one of the
only multicentre studies that septal E/e’ was associated with prior is-
chaemic stroke in 330 AF patients with LVEF >40% (adjusted odds
ratio 1.21, 95% CI 1.08–1.37; P= 0.002), unlike clinical and
through other sources (n=14) database searching (n=3052) 
Titles and abstracts screened (n=3066) 
Records excluded (n=2945): 
 Case reports (n=546) 
 Not relevant to echocardiography/AF (n=2399) 
 No outcomes of interest (n=30) 
 Opinion piece/informal review (n=12)  
 No validity or reproducibility data (n=26) 
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Figure 1 Systematic review flowchart. AF, atrial fibrillation.
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echocardiographic parameters such and age, BNP, or LVEF.18 E/e’
also correlates with 6-min walk distance and quality of life, as seen in
a retrospective study of 48 patients with AF and preserved LVEF.26
Reproducibly of diastolic indices is summarized in Table 4, with
intra- and inter-observer mean differences, coefficients of variation,
and test-retest variability reasonable in the majority of the 23 studies
(n= 997).10,13,15,20–27,34–36 Of note, E/e’ was shown to be reliable
when measured 1 week apart (correlation coefficient 0.87,
P< 0.05),26 and the variability of diastolic indices was similar in AF
and sinus rhythm in a small cohort of patients from the Framingham
study.13
Acquisition: cycle length and cycle
repeats
The irregular RR interval in AF has led to concern about the reliability
of both systolic and diastolic measures, and there is clinical uncer-
tainty about the number of repeated measures required and optimal
cycle length. Historical data have shown that the RR interval affects
LVEF in AF patients, more so than in sinus rhythm.8 More recent
studies have confirmed that the cycle length of preceding RR intervals
in AF is strongly related to stroke volume.37 LV ejection velocity is
lower when pre-preceding RR intervals are longer, and differences in
systolic performance are minimized when the preceding and pre-
preceding RR interval lengths are similar.28 Beat-to-beat variability in
stroke volume increases as heart rate increases in AF patients,40 and
the effect of preceding and pre-preceding RR intervals on stroke vol-
ume is most pronounced at higher heart rates.14
With regard to the number of repeated measurements required,
when preceding and pre-preceding RR interval lengths are equivalent
(<60 ms difference), measurement of PLSS in patients with persistent
or permanent AF was similar using a single index-beat, as compared
to averaging 15 cardiac cycles (r= 0.97, P< 0.001).19 In another study,
index-beat assessment gave similar values to 10-s averages for
myocardial strain and strain rate (r= 0.94, P< 0.001).16 The benefit of
averaging a number of beats with similar preceding and pre-
preceding RR intervals and with cycle lengths of 500 ms or greater
was confirmed in two further studies.38,39 Using 3D volume datasets,
a single-beat measurement in AF had lower variability than conven-
tional 4-beat acquisition,29 although whether a single-beat analysis
has the same association with clinical outcomes is currently un-
known. For diastolic function, retest variability of E/e’ was similar
over 10 or 50 cardiac cycles in AF patients with preserved LVEF.20 In
another study of post-operative AF patients, the correlation of E/e’
to PCWP was no different when sampling over 10 beats or in a single
cycle with the longest RR interval (r = 0.47 and 0.44, respectively).27
These results suggest that choosing appropriate cardiac cycles
with similar RR interval is more important than the absolute number
of cycles measured (Figure 2). Of clinical importance, Nagueh et al.
found less Doppler variability in patients at higher LV filling pres-
sure,22 suggesting that measurement error might actually be reduced
in those patients at the highest risk of adverse events.
Discussion
The main findings of this systematic review were that diastolic indices,
in particular E/e’, were valid and reproducible in patients with AF,
whereas data for systolic parameters were extremely limited. We
also identified consensus amongst numerous studies that the optimal
acquisition of echocardiography in AF patients occurred when pre-
ceding and pre-preceding cycle lengths are equivalent, rather than ac-
cording to the number of repeated measurements taken. These
.................................................................................................
Table 3 Reproducibility of systolic echocardiographic
measures in AF
Parameter/Study N Reproducibility
Intra-observer and
inter-observer variability
Simpson’s LVEF:
Wang, 200639 10 Single-beat intra 2.8%
3-dimensional LVEF:
Shahgaldi, 201029 23 4-beat intra 8.3%, inter 17.9%
Single beat intra 4.8%, inter 5.6%
Peak longitudinal
systolic strain:
Lee, 201219 15 15-cycle average intra 2.4%,
inter 2.7%
Single index beat intra 3.5%,
inter 4.0%
Global longitudinal straina:
Su, 201332 30 Intra 5.3%, inter 6.2%
Myocardial performance
indexb:
Su, 201131 54 Intra 5.2%, inter 7.3%
aUsing single index beat;
bA marker of combined systolic and diastolic function calculated as the sum of
pre-ejection time and isovolumic relaxation time as a ratio of ejection time.
LVEF, left ventricular ejection fraction.
.................................................................................................
Table 2 Pooled characteristics
Characteristic Range of
reported
means
Weighted
average
(standard
deviation
of means)
Number of
studies/
number of
patients
Age 57–76 years 66.9 (4.5) years 31/1916
Women 0–52% 33 (11) % 27/1835
Hypertension 17–85% 53 (18) % 11/1235
Heart failure 0–100% 48 (35) % 14/1473
LVEF 22–65% 52.5 (9.7) % 25/1646
E/e’:
Average 9–23 11.7 (2.7) 5/437
Septal 11–23 13.4 (4.7) 2/560
Lateral 8–14 10.3 (2.1) 5/196
Heart rate 63–107
beats/min
79.9 (6.3)
beats/min
20/1223
Pooled baseline characteristics, weighted according to sample size. E/e’, ratio of
mitral peak E velocity and tissue Doppler early diastolic filling e’; LVEF, left ven-
tricular ejection fraction.
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findings have important clinical impact, dispelling preconceptions
about the utility of diastolic variables, highlighting key areas in need of
further prospective study, and improving the diagnostic value of
echocardiography in patients with AF (Figure 3).
Echocardiography is a vital part of the assessment of AF patients,
and is now recommend in all AF patients to guide management (class
I, level of evidence C).1 Numerous narrative reviews have been pub-
lished concerning both systolic and diastolic function, however, this is
the first systematic assessment of the validity and reproducibility of
measurements. Echocardiography is an important component of ini-
tial management and is cost-effective for newly diagnosed patients
with AF.41 Knowledge about the type of heart failure in AF
....................................................................................................................................................................................................................
Table 4 Validity and reproducibility of diastolic echocardiographic measures in AF
Parameter/Study N Diastolic validation Diastolic reproducibility Mean LVEF
(SD) %Correlation with invasive
pulmonary capillary wedge
pressure (r)
Intra-observer and inter-observer
mean differences (MD)6 standard
deviation, coefficient of variation (CV),
retest correlation (RC) or retest
variability (RV)
Isovolumic relaxation time (IVRT):
Nagueh, 199622 30 –0.76‡ Intra MD 1.4 ± 8.4 ms, inter MD 4.5 ± 9.0 msb 45 (16)
Temporelli, 199934 35 –0.95‡ CV 1.9–2.4%c 22 (5)
Traversi, 200135 51 –0.70‡ Intra MD 0.15 ± 0.15, inter MD 0.25 ± 1.64 mmHgf 25 (7)
Diwan, 200511 13 –0.92†,a 54 (11)
Punjani, 201126 48 Intra RC 0.54
Mitral E wave deceleration time:
Galderisi, 199213 12 Intra RC 0.85–0.93, inter RC 0.76
Nagueh, 199622 30 –0.42* Intra MD 1.0 ± 4.0 ms; inter MD 5.4 ± 7.8 msb 45 (16)
Chirillo, 199710 35 –0.50† CV “not statistically significant” 41 (13)
Sohn, 199930 27 no correlation 53 (11)
Temporelli, 199934 35 –0.70† CV 1.9–2.4%c 22 (5)
Matsukida, 200121 32 –0.65‡ Intra RV 5.1%, inter RV 5.6%c g
Traversi, 200135 51 –0.60‡ 25 (7)
Peltier, 200825 30 Intra RC 0.88, inter RC 0.84. 31 (8)
Senechal, 200827 24 no correlation Intra RV 1.2–3.6%, inter RV 2.3–4.8%c,e 46 (15)
Punjani, 201126 48 Intra RC 0.75
Ratio of mitral peak E velocity and tissue Doppler e’ (E/e’):
Sohn, 199930 27 Septal 0.79‡ 53 (11)
Okura, 200623 230 Septal intra RV 5.0%, inter RV 11.4% 56 (12)
Senechal, 200827 24 Lateral 0.47*, septal 0.46* Intra RV 1.2–3.6%, inter RV 2.3–4.8%c,e 46 (15)
Kusunose, 200915 21 Lateral 0.57†, single-beat lateral 0.74‡ Single-beat lateral intra RV 4.9%, inter RV 6.6%d 60 (6)
Li, 201020 49 Lateral 0.49‡, single-beat lateral 0.77‡ Single-beat lateral intra RV 6.7%, inter RV 7.9% 59 (8)
Punjani, 201126 48 Lateral intra RC 0.84, septal intra RC 0.86
Wada, 201236 45 Average single-beat 0.57‡ Single-beat average intra RV 4.3%, inter RV 11.1% 52 (16)
Ratio of mitral peak E velocity and velocity of diastolic flow propagation (E/Vp):
Nagueh, 199622 30 0.65‡ Intra MD 0.2 ± 0.4 ms, inter MD 0.13 ± 0.40 msb 45 (16)
Oyama, 200424 25 0.63† Intra RV 5.1%, inter 5.3% 55 (15)
Punjani, 201126 48 Intra RC 0.79
Pulmonary venous flow diastolic wave deceleration time (PVd-DT):
Chirillo, 199710 35 –0.91‡ CV “not statistically significant” 41 (13)
Matsukida, 200121 32 –0.80‡ Intra RV 5.1%, inter RV 5.6%c g
Retest variability typically expressed as the mean percentage error.
aIVRT as a ratio to the difference between onset time of mitral E and annulus e’ velocities.
bN= 7 for reproducibility data.
cCombined reproducibility assessment for all Doppler variables.
dN= 10 for reproducibility data.
eN= 6 for reproducibility data.
fN= 40 for reproducibility data; based on a composite of IVRT, deceleration rate and systolic fraction.
gFractional shortening 29% (SD 4%).
LVEF, left ventricular ejection fraction.
*P<_ 0.05.
†
P<_ 0.01.
‡
P< 0.001.
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Figure 3 Summary of findings for echocardiography in AF. AF, atrial fibrillation; E/e’, ratio of mitral peak E velocity and tissue Doppler early diastolic
filling e’; E/Vp, ratio of mitral peak E velocity and the velocity of diastolic flow propagation; IVRT, isovolumic relaxation time; PCWP, pulmonary capil-
lary wedge pressure; PVd-DT, pulmonary venous diastolic flow deceleration time.
Figure 2 Example of optimal acquisition (index beat method). In order to achieve the most valid and reproducible measurement in atrial fibrilla-
tion, parameters should be acquired where the two preceding cardiac cycles have similar RR-intervals and preferably where the equivalent heart rate
is < 100 beats/min (panel A). This method can also be applied to assessment of function; averaging individual index beats is preferable to averaging
across sequential cardiac cycles (panel B).
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(preserved or reduced ejection fraction), has an important bearing
on prognosis.42 Identifying reduced LVEF also has consequences for
the choice of rate- and rhythm-control therapy, for example the
choice of beta-blockers or digoxin,43,44 and the avoidance of non-
dihydropyridine calcium channel blockers and class I anti-arrhythmic
drugs. Echocardiography is also vital for the planning and follow-up of
patients undergoing catheter, surgical and hybrid ablation for AF, as
well as left atrial appendage closure.
As all of the studies were undertaken on patients in AF, the pooled
data gives clinical guidance as to expected average values. The
weighted-mean LVEF was 52.5%, and although a number of studies
either excluded or only enrolled those with heart failure, this was
similar to the RealiseAF Global Registry (LVEF 54.3% in persistent
and 53.3% in permanent AF).4 E/e’ values were consistently higher
than seen in 103 healthy volunteers (lateral E/e’ 6.2 ± 1.8 in age-range
60-69 years)45 but similar to 100 sinus rhythm patients undergoing
coronary angiography46 and 951 sinus rhythm patients with isolated
diastolic dysfunction and e’/a’ <1.47 However, even though average
estimates are likely to be higher in AF patients (with associated
comorbidities) than sinus rhythm, the cut-off value of E/e’ >15 was
still a good marker of adverse events and functional capacity in AF.
Validation of E/e’ against invasive filling pressure was reasonable in
AF, and similar to correlation values published in sinus rhythm. For
sinus rhythm, this includes lateral E/e0 r= 0.51 in 100 patients, lateral
E/e’ r= 0.86 in 100 patients, and septal E/e’ r= 0.46 in 60 echocardio-
gram studies in 15 patients.46,48,49 However, a recent systematic re-
view of E/e’ in sinus rhythm identified concerns over reliability of this
parameter to estimate LV filling pressure.50
In all cases, there is the assumption that echocardiographic param-
eters are reliable in AF, despite the irregular ejection and rate. We
have shown that stroke volume and LVEF do vary according to cycle
length, particularly in respect to the RR intervals preceding measure-
ment. In contrast to sinus rhythm, echocardiographers need to care-
fully appraise how and when to acquire measurements in order to
accurately identify LV dysfunction in AF patients. Simultaneous as-
sessment of both E and e’ are now available in order to provide a
single-beat analysis of E/e’ (dual Doppler method). There are theor-
etical advantages to this process in reducing error, particularly in AF
where successive beats are likely to vary. The dual Doppler method
appears to offer better validation vs. invasive PCWP (see Table 4),
and in one study conferred a smaller amount of variability in E/e’ be-
tween operators (7.1% vs. 13.4% using conventional analysis over 10
cycles).20 However, it is unclear if this has any advantage over prop-
erly acquired index-beat assessment, and availability in clinical prac-
tice is currently limited. Whereas a properly acquired index-beat
assessment approach, based on our data, should achieve good levels
of validity and reproducibility for diastolic indices, the data on systolic
parameters is clearly inadequate. It is unclear which measure of sys-
tolic function is best for patients who are scanned whilst in AF, and
this should be a priority for future research. Although global strain at
a low cut-off was associated with outcomes in one of the studies re-
viewed,32 more recent data suggests that the association of strain
with mortality is attenuated in patients with AF and heart failure with
reduced LVEF (p value for interaction = 0.036).51 Further prospective
studies, either in the context of controlled trials52 or in routine clin-
ical practice, are urgently needed to support the large volume of
echocardiograms performed in patients with AF. As clinicians, we
also need to know the minimum number of index beats required to
maintain equivalence but reduce the time required for scanning, and
for confirmation of reproducibility at different heart rates and grades
of systolic and diastolic LV dysfunction.
Study limitations
There are numerous limitations to our review, most notably the risk
of bias, particularly selection and blinding bias, as patients were often
selected on the basis of echocardiogram quality. However, this is no
different to studies in sinus rhythm. There are likely to be other stud-
ies assessing the reproducibility of echo parameters in AF, missed by
our systematic search if reproducibility was not listed as a major out-
come. We were unable to perform meta-analysis, not only because
of the lack of published standard deviations for validation and repro-
ducibility measures, but also the heterogeneity of populations as-
sessed. Although most studies made reference to ‘chronic AF’, the
duration and type of AF was often not disclosed. Most of the studies
excluded valve disease (with differing definitions) and there was lim-
ited data above a heart rate of 100 beats/min. Finally, considering the
importance of diagnosing heart failure in patients with AF, and how
common these conditions are in clinical practice, the relatively small
number of studies identified in this systematic review is a surprising
limitation, and one that requires further attention.
Conclusions
In selected patients with atrial fibrillation, diastolic echocardio-
graphic parameters have been validated against invasive filling pres-
sure, and E/e’ is an independent marker of functional impairment
and adverse prognosis. Averaging single-beat assessments are re-
producible and should be acquired in cycles with similar preceding
length and controlled heart rate. However, data on the validity and
reproducibility of systolic indices are extremely limited. Considering
the importance of heart failure and assessment of systolic function
in AF, further assessment of variability in routine clinical practice is
urgently needed.
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